Albert Dahan

About

Albert Dahan is a leading anesthesiologist and clinical researcher whose work has fundamentally shaped modern neuromuscular monitoring and perioperative safety. His primary research areas include the depth of neuromuscular block (NMB), anesthetic pharmacology, and intraoperative patient outcomes. Dr. Dahan is best known for spearheading the EURO-RELAX TRIAL (2021), a landmark international multicenter randomized controlled trial that directly compared deep versus standard neuromuscular block during laparoscopic surgery. This study provided critical evidence on how NMB depth impacts surgical conditions and patient safety, influencing clinical guidelines worldwide. He also co-authored the influential "Proposal for a Revised Classification of the Depth of Neuromuscular Block" (2019), which established a standardized framework for neuromuscular monitoring—a foundational reference cited over 17 times. With a career dedicated to bridging technical advances in monitoring equipment with practical anesthesia care, Dr. Dahan’s work has been cited extensively, reflecting its impact on both clinical practice and research. His contributions continue to guide anesthesiologists in optimizing muscle relaxation for safer, more effective surgical outcomes.

Research Focus

Key Achievements

Top Papers

1. 1
   Proposal for a Revised Classification of the Depth of Neuromuscular Block and Suggestions for Further Development in Neuromuscular Monitoring

   17 citations · 2019
2. 2
   The impact of deep versus standard neuromuscular block on intraoperative safety during laparoscopic surgery: an international multicenter randomized controlled double-blind strategy trial — EURO-RELAX TRIAL

   6 citations · 2021

Key Collaborators

Contact & Links